OraSure Technologies (OSUR) Competitors $2.99 -0.07 (-2.29%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock OSUR vs. STAA, CERS, ANIK, UTMD, COO, WST, ALGN, MMSI, ICUI, and HAEShould you be buying OraSure Technologies stock or one of its competitors? The main competitors of OraSure Technologies include STAAR Surgical (STAA), Cerus (CERS), Anika Therapeutics (ANIK), Utah Medical Products (UTMD), Cooper Companies (COO), West Pharmaceutical Services (WST), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), and Haemonetics (HAE). These companies are all part of the "health care supplies" industry. OraSure Technologies vs. STAAR Surgical Cerus Anika Therapeutics Utah Medical Products Cooper Companies West Pharmaceutical Services Align Technology Merit Medical Systems ICU Medical Haemonetics OraSure Technologies (NASDAQ:OSUR) and STAAR Surgical (NASDAQ:STAA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, media sentiment, risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations. Do institutionals and insiders believe in OSUR or STAA? 93.5% of OraSure Technologies shares are held by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are held by institutional investors. 3.9% of OraSure Technologies shares are held by company insiders. Comparatively, 1.0% of STAAR Surgical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has better earnings and valuation, OSUR or STAA? OraSure Technologies has higher earnings, but lower revenue than STAAR Surgical. STAAR Surgical is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOraSure Technologies$185.83M1.25$53.65M-$0.26-11.50STAAR Surgical$313.90M2.87-$20.21M-$0.41-44.54 Do analysts recommend OSUR or STAA? OraSure Technologies presently has a consensus price target of $5.50, suggesting a potential upside of 83.95%. STAAR Surgical has a consensus price target of $24.25, suggesting a potential upside of 32.80%. Given OraSure Technologies' higher possible upside, analysts clearly believe OraSure Technologies is more favorable than STAAR Surgical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OraSure Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00STAAR Surgical 1 Sell rating(s) 9 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media prefer OSUR or STAA? In the previous week, STAAR Surgical had 5 more articles in the media than OraSure Technologies. MarketBeat recorded 8 mentions for STAAR Surgical and 3 mentions for OraSure Technologies. OraSure Technologies' average media sentiment score of 1.18 beat STAAR Surgical's score of 0.97 indicating that OraSure Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OraSure Technologies 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive STAAR Surgical 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor OSUR or STAA? OraSure Technologies received 264 more outperform votes than STAAR Surgical when rated by MarketBeat users. Likewise, 69.13% of users gave OraSure Technologies an outperform vote while only 54.12% of users gave STAAR Surgical an outperform vote. CompanyUnderperformOutperformOraSure TechnologiesOutperform Votes55369.13% Underperform Votes24730.88% STAAR SurgicalOutperform Votes28954.12% Underperform Votes24545.88% Is OSUR or STAA more profitable? OraSure Technologies has a net margin of 5.07% compared to STAAR Surgical's net margin of -6.44%. OraSure Technologies' return on equity of 3.55% beat STAAR Surgical's return on equity.Company Net Margins Return on Equity Return on Assets OraSure Technologies5.07% 3.55% 3.23% STAAR Surgical -6.44%-3.35%-2.67% Which has more risk and volatility, OSUR or STAA? OraSure Technologies has a beta of 0.76, indicating that its share price is 24% less volatile than the S&P 500. Comparatively, STAAR Surgical has a beta of 0.75, indicating that its share price is 25% less volatile than the S&P 500. SummaryOraSure Technologies beats STAAR Surgical on 12 of the 17 factors compared between the two stocks. Get OraSure Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for OSUR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OSUR vs. The Competition Export to ExcelMetricOraSure TechnologiesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$231.69M$4.38B$5.57B$7.83BDividend YieldN/A39.98%5.11%4.21%P/E Ratio19.9330.6722.4418.48Price / Sales1.2554.91394.10103.59Price / Cash2.8951.0838.1834.62Price / Book0.516.116.774.25Net Income$53.65M$68.15M$3.22B$248.23M7 Day Performance-0.33%1.41%3.25%3.29%1 Month Performance-12.83%-4.21%0.01%2.42%1 Year Performance-43.48%24.42%18.00%5.54% OraSure Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OSUROraSure Technologies4.6222 of 5 stars$2.99-2.3%$5.50+83.9%-43.5%$231.69M$185.83M19.93840Upcoming EarningsPositive NewsSTAASTAAR Surgical4.3746 of 5 stars$16.53-2.1%$24.25+46.7%-60.3%$815.34M$313.90M-40.32960Upcoming EarningsCERSCerus2.078 of 5 stars$1.29-0.8%$3.50+171.3%-21.0%$239.67M$180.27M-11.73290Upcoming EarningsNews CoverageANIKAnika Therapeutics4.0535 of 5 stars$14.03+0.1%$21.67+54.4%-43.9%$198.89M$119.91M-2.11300Positive NewsUTMDUtah Medical Products2.5343 of 5 stars$52.50+0.4%N/A-21.8%$172.31M$40.90M13.29180Earnings ReportNews CoverageCOOCooper Companies3.3067 of 5 stars$78.70-1.0%$110.25+40.1%-8.3%$15.74B$3.93B40.3614,000WSTWest Pharmaceutical Services4.6418 of 5 stars$206.02+2.0%$332.50+61.4%-40.9%$14.89B$2.89B30.8010,700Earnings ReportDividend AnnouncementAnalyst RevisionALGNAlign Technology4.3503 of 5 stars$172.22+0.5%$256.90+49.2%-38.6%$12.61B$4.00B30.7023,200Analyst ForecastNews CoverageMMSIMerit Medical Systems3.9633 of 5 stars$89.60-1.4%$114.33+27.6%+27.5%$5.29B$1.36B43.926,850Earnings ReportShort Interest ↑Analyst RevisionICUIICU Medical3.8494 of 5 stars$136.72-1.4%$162.67+19.0%+39.5%$3.35B$2.38B-29.9214,500Upcoming EarningsPositive NewsHAEHaemonetics4.6271 of 5 stars$57.03-0.2%$101.22+77.5%-31.5%$2.87B$1.37B22.452,820Positive News Related Companies and Tools Related Companies STAAR Surgical Competitors Cerus Competitors Anika Therapeutics Competitors Utah Medical Products Competitors Cooper Companies Competitors West Pharmaceutical Services Competitors Align Technology Competitors Merit Medical Systems Competitors ICU Medical Competitors Haemonetics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OSUR) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OraSure Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OraSure Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OSUR Stock Free OSUR Stock Alerts